China Resources Pharmaceutical Group Ltd.
3320
Clasificación en acciones
#4220
China Resources Pharmaceutical Group Limited, an investment holding company,... China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Precio por acción
$0.59869476
Capitalización bursátil
$3.76B
Cambio (1 día)
1.63%
Cambio (1 año)
-2.09%
País
HK
Comercio China Resources Pharmaceutical Group Ltd. (3320)
Categoría
Healthcare
EPS de China Resources Pharmaceutical Group Ltd. (3320)
EPS a fecha de June 2026 TTM: $0.10
Según los últimos informes financieros y el precio de las acciones de China Resources Pharmaceutical Group Ltd., el EPS actual de la empresa (TTM) es $0.10. Al final del año 2023, la empresa tenía un EPS de $0.09 un aumento con respecto a al EPS de 2022, que fue de $0.08.
Historial de EPS de China Resources Pharmaceutical Group Ltd. desde 2013 hasta 2026
EPS al final de cada año
| Año | EPS | Cambiar |
|---|---|---|
| 2026 (TTM) | $0.10 | 37.00% |
| 2024 | $0.07 | -17.22% |
| 2023 | $0.09 | 3.08% |
| 2022 | $0.08 | 9.74% |
| 2021 | $0.08 | 14.75% |
| 2020 | $0.07 | 0.45% |
| 2019 | $0.07 | -18.24% |
| 2018 | $0.08 | 16.05% |
| 2017 | $0.07 | -4.22% |
| 2016 | $0.07 | -8.13% |
| 2015 | $0.08 | 44.40% |
| 2014 | $0.06 | -0.18% |
| 2013 | $0.06 | 0.00% |
EPS de empresas similares o competidoras
| Empresa | EPS | Diferencia de EPS | País |
|---|---|---|---|
| $2.41 | 2,413.03% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $0.02 | -80.40% |
HK
|
